In concordance, although the source of MMP-9 cannot be identified when measuring circulating levels, it has been shown repeatedly that levels of circulating MMP-9 are elevated in patients with CHD, in particular those with acute coronary syndrome [3, 10–14]. Here, MMP9 is linked to coronary artery disorder.